1998•ThoraxOpen access

Rifampicin containing antituberculosis medication

Gillian F Cavell, D. C. S. Hutchison, B C WHITEMAN

Open full text 0 citations

Abstract

We wish to draw attention to the potential for error in the prescribing and dispensation of antituberculous drugs containing rifampicin. Most prescriptions for patients with tuberculosis contain rifampicin; this drug must be administered with other chemotherapeutic agents, most commonly isoniazid and pyrazinamide, in order to avoid the emergence of drug resistant organisms. Patient compliance is much improved by the prescription of “combination therapy”. Guidelines for the management of tuberculosis are available1 and the drug regimens specified by the Joint Tuberculosis Committee of the …

Open-access reader

About this research paper

What this paper is about

We wish to draw attention to the potential for error in the prescribing and dispensation of antituberculous drugs containing rifampicin. Most prescriptions for patients with tuberculosis contain rifampicin; this drug must be administered with other chemotherapeutic agents, most commonly isoniazid and pyrazinamide, in order to avoid the emergence of drug resistant organisms. Patient compliance is much improved by the prescription of “combination therapy”. Guidelines for the management of tuberculosis are available1 and the drug regimens specified by the Joint Tuberculosis Committee of the …

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

We wish to draw attention to the potential for error in the prescribing and dispensation of antituberculous drugs containing rifampicin. Most prescriptions for patients with tuberculosis contain rifampicin; this drug must be administered with other chemotherapeutic agents, most commonly isoniazid and pyrazinamide, in order to avoid the emergence of drug resistant organisms. Patient compliance is much improved by the prescription of “combination therapy”. Guidelines for the management of tuberculosis are available1 and the drug regimens specified by the Joint Tuberculosis Committee of the …

Key concepts: Medicine, Rifampicin, Pyrazinamide, Tuberculosis, Isoniazid, Medical prescription, Drug, Intensive care medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Rifampicin containing antituberculosis medication — Research Paper | ScholarLens